Purchase Order 75N91020P00816
Award Date 9/21/20
Potential Completion Date 10/18/20
Potential Value $54K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Alameda, CA 94502, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) valued at $177,816 on September 24, 2021, for a laser capture microdissection system. The order was issued as a simplified acquisition without a set-aside to de-obligate expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a). Work is performed at Bethesda, Maryland. The order's ultimate completion date was October 22, 2021. The originating solicitation, posted...
- <p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) for biological and reagent material valued at $13,690.00 on March 5, 2021, with completion scheduled for July 7, 2021. No set-aside was applied. Performance takes place in South San Francisco, California. The order is a firm fixed-price procurement for direct-use biological and reagent materials.</p>
- The National Cancer Institute awarded a purchase order to Pavilion Integration Corporation for $195,000 on August 30, 2019, under a Total Small Business set-aside. The order procures an N30 Flow Nanoanalyzer for detection and resolution of single molecules and single extracellular vesicles in support of NCI's Center for Cancer Research. Performance is located in San Jose, California. The purchase order carries firm fixed-price terms with an ultimate completion date of September 29, 2019. The...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order contract worth $126,311.80 to Fluxion Biosciences Inc., a manufacturer of automated patch clamp, cellular analysis, and liquid biopsy systems. The contract is for a "Recombinant Cell Line" with a completion date of September 30, 2021. Fluxion Biosciences Inc. has previously provided specialized biofluxion equipment, upgrades, cell lines, and microfluidic...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $148,545.00 firm-fixed-price purchase order contract to Fluxion Biosciences Inc., a manufacturer of automated patch clamp, cellular analysis, and liquid biopsy systems. The contract is for the delivery of laboratory equipment and has a completion date of September 30, 2020. This contract does not have a set-aside designation. Fluxion Biosciences has previously provided specialized bio fluxion...
- <p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc., doing business as Fluidigm, valued at $16,020.00, on May 7, 2018. No set-aside category was used. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of July 10, 2019 and carries firm fixed pricing.</p>
- <p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on September 7, 2017, with a ceiling value of $6,088.50. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is October 9, 2017. Pricing is firm fixed price. The specific requirements are not detailed in the source material.</p>
- <p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) for $13,104.90 on July 3, 2018, with an ultimate completion date of July 3, 2019. The order, issued on a firm fixed price basis with no set-aside, procures antibodies. Place of performance is Bethesda, Maryland.</p>
- <p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) valued at $23,348.60 on August 24, 2018, with ultimate completion on August 23, 2019. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is a firm fixed price commercial purchase; specific requirements are not detailed in the award notice.</p>
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $110,000 firm fixed price purchase order to Fluxion Biosciences Inc. (doing business as Fluxion) to upgrade the Ionflux Mercury 16 to a 96- to 386-well capability. This sole source contract was awarded without a set-aside, and is for supplies or services for which the government intends to contract with only one source under the authority of FAR 13.106-1(b)(1) and 10 U.S.C. 2304(c)(1). The upgrade is...
The National Cancer Institute awarded a purchase order to Fluxion Biosciences Inc. for $53,803.00 on September 21, 2020, under a total small business set-aside for procurement of a Fluxion Bioflux 200 microfluidic device system in support of the National Cancer Institute's Center for Cancer Research, Laboratory of Molecular Biology. The order is firm fixed price with an ultimate completion date of October 18, 2020. Place of performance is Alameda, California. The originating solicitation, posted August 17, 2020, with a due date of August 24, 2020, carried the same small business set-aside designation.
Generated 5/31/26, 9:58 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Procurement of a Brand Name or Equal Fluxion Bioflux 200 microfluidic device system | 75N91020Q00146 | Department of Health and Human Services National Institutes of Health National Cancer Institute | Solicitation 1/1 | 8/17/20, 3:11 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.8k | 9/17/20 |